{"transactions":[{"id":1934094,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":114914,"kind":"person","name":"Roberts William T.","position":1,"cik":"0001852360","reported_name":"Roberts William T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-31T21:38:20.000Z","date":"2023-03-29","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest or have vested as to 50% of the shares on each of March 29, 2024 and March 29, 2025. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest or have vested as to 50% of the shares on each of March 29, 2024 and March 29, 2025. The restricted stock units have no expiration date."}],"balance_after":5000,"derivative":{"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001104659-23-040415","document":"tm2311181-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1852360/000110465923040415/tm2311181-1_4seq1.xml","form_type":"4"}},{"id":1934093,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":114914,"kind":"person","name":"Roberts William T.","position":1,"cik":"0001852360","reported_name":"Roberts William T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-03-31T21:38:20.000Z","date":"2023-03-29","kind":"sale","planned":false,"acquired":false,"shares":912,"price":17.5,"value":15960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units."}],"balance_after":7872,"source":{"system":"sec-edgar","filing":"0001104659-23-040415","document":"tm2311181-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1852360/000110465923040415/tm2311181-1_4seq1.xml","form_type":"4"}},{"id":1934092,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":114914,"kind":"person","name":"Roberts William T.","position":1,"cik":"0001852360","reported_name":"Roberts William T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-03-31T21:38:20.000Z","date":"2023-03-29","kind":"exercise","planned":false,"acquired":true,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."}],"balance_after":8784,"source":{"system":"sec-edgar","filing":"0001104659-23-040415","document":"tm2311181-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852360/000110465923040415/tm2311181-1_4seq1.xml","form_type":"4"}},{"id":2016856,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":114914,"kind":"person","name":"Roberts William T.","position":1,"cik":"0001852360","reported_name":"Roberts William T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-02-14T19:27:13.000Z","date":"2023-02-09","kind":"sale","acquired":false,"shares":969,"price":27.51,"value":26657.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported Restricted Share Units."}],"balance_after":6284,"source":{"system":"sec-edgar","filing":"0001104659-23-022071","document":"tm236871-5_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852360/000110465923022071/tm236871-5_4aseq1.xml","form_type":"4/A","original_submission_date":"2023-02-13"}},{"id":2020213,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":114914,"kind":"person","name":"Roberts William T.","position":1,"cik":"0001852360","reported_name":"Roberts William T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-13T17:02:36.000Z","date":"2023-02-09","kind":"exercise","acquired":false,"shares":2313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest or have vested as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest or have vested as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date."}],"balance_after":6937,"derivative":{"underlying":"Common Stock","underlying_shares":2313},"source":{"system":"sec-edgar","filing":"0001104659-23-019824","document":"tm236605-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1852360/000110465923019824/tm236605-3_4seq1.xml","form_type":"4"}},{"id":2020212,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":114914,"kind":"person","name":"Roberts William T.","position":1,"cik":"0001852360","reported_name":"Roberts William T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-02-13T17:02:36.000Z","date":"2023-02-09","kind":"sale","acquired":false,"shares":959,"price":27.66,"value":26525.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported Restricted Share Units."}],"balance_after":6294,"source":{"system":"sec-edgar","filing":"0001104659-23-019824","document":"tm236605-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1852360/000110465923019824/tm236605-3_4seq1.xml","form_type":"4"}},{"id":2020211,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":114914,"kind":"person","name":"Roberts William T.","position":1,"cik":"0001852360","reported_name":"Roberts William T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-02-13T17:02:36.000Z","date":"2023-02-09","kind":"exercise","acquired":true,"shares":2313,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,463 shares acquired under Issuer's Employee Stock Purchase Plan on February 28, 2022 and August 31, 2022."}],"balance_after":7253,"source":{"system":"sec-edgar","filing":"0001104659-23-019824","document":"tm236605-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852360/000110465923019824/tm236605-3_4seq1.xml","form_type":"4"}},{"id":2313100,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":114914,"kind":"person","name":"Roberts William T.","position":1,"cik":"0001852360","reported_name":"Roberts William T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2022-03-31T16:31:08.000Z","date":"2022-03-29","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest or have vested as to 25% of the total shares on each of March 29, 2022, March 29, 2023, March 29, 2024 and March 29, 2025. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest or have vested as to 25% of the total shares on each of March 29, 2022, March 29, 2023, March 29, 2024 and March 29, 2025. The restricted stock units have no expiration date."}],"balance_after":7500,"derivative":{"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001104659-22-041079","document":"tm2211062-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1852360/000110465922041079/tm2211062-1_4seq1.xml","form_type":"4"}},{"id":2313099,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":114914,"kind":"person","name":"Roberts William T.","position":1,"cik":"0001852360","reported_name":"Roberts William T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-03-31T16:31:08.000Z","date":"2022-03-29","kind":"sale","acquired":false,"shares":1023,"price":11.13,"value":11385.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported Restricted Share Units."}],"balance_after":1477,"source":{"system":"sec-edgar","filing":"0001104659-22-041079","document":"tm2211062-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1852360/000110465922041079/tm2211062-1_4seq1.xml","form_type":"4"}},{"id":2313098,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":114914,"kind":"person","name":"Roberts William T.","position":1,"cik":"0001852360","reported_name":"Roberts William T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-03-31T16:31:08.000Z","date":"2022-03-29","kind":"exercise","acquired":true,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001104659-22-041079","document":"tm2211062-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852360/000110465922041079/tm2211062-1_4seq1.xml","form_type":"4"}},{"id":2401989,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":114914,"kind":"person","name":"Roberts William T.","position":1,"cik":"0001852360","reported_name":"Roberts William T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2022-02-11T21:35:59.000Z","date":"2022-02-09","kind":"grant","acquired":true,"shares":9250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date."}],"balance_after":9250,"derivative":{"underlying":"Common Stock","underlying_shares":9250},"source":{"system":"sec-edgar","filing":"0001104659-22-020898","document":"tm226394-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1852360/000110465922020898/tm226394-9_4seq1.xml","form_type":"4"}},{"id":2401988,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":114914,"kind":"person","name":"Roberts William T.","position":1,"cik":"0001852360","reported_name":"Roberts William T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-11T21:35:59.000Z","date":"2022-02-09","kind":"grant","acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options were granted on February 9, 2022. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date."}],"balance_after":18500,"derivative":{"exercise_price":6.8,"expiration_date":"2032-02-08","underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0001104659-22-020898","document":"tm226394-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852360/000110465922020898/tm226394-9_4seq1.xml","form_type":"4"}},{"id":2768252,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":114914,"kind":"person","name":"Roberts William T.","position":1,"cik":"0001852360","reported_name":"Roberts William T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2021-03-30T16:49:23.000Z","date":"2021-03-29","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest as to 25% of the total shares on each of March 29, 2022, March 29, 2023, March 29, 2024 and March 29, 2025. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest as to 25% of the total shares on each of March 29, 2022, March 29, 2023, March 29, 2024 and March 29, 2025. The restricted stock units have no expiration date."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-21-043951","document":"tm2111372-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1852360/000110465921043951/tm2111372-1_4seq1.xml","form_type":"4"}},{"id":2768251,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":114914,"kind":"person","name":"Roberts William T.","position":1,"cik":"0001852360","reported_name":"Roberts William T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-30T16:49:23.000Z","date":"2021-03-29","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options were granted on March 29, 2021. 25% of the shares subject to the option will vest and become exercisable on March 29, 2022 and the remaining 75% of the shares subject to the option shall vest and become exercisable in 12 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer thereafter."}],"balance_after":20000,"derivative":{"exercise_price":20.25,"expiration_date":"2031-03-28","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-21-043951","document":"tm2111372-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852360/000110465921043951/tm2111372-1_4seq1.xml","form_type":"4"}}]}